2 results
Approved WMOCompleted
The primary objective is to determine the effectiveness of RSWT versus FSWT in treating patellar tendinopathy.
Approved WMOCompleted
Compare Progression Free Survival (PFS) for brivanib versus placebo in subjects with advanced solid tumors with FGF-2 over-expression and who have obtained stable disease after 12 weeks of treatment with brivanib separately for each tumor.